In a new article published in Psychiatric Times, NCCHC Correctional Mental Health Conference speakers Alan Abrams, MD, JD, and Nicolas Badre, MD, and a colleague share insights related to Lethal Suicide Deniers — patients who die by suicide within 24 hours of denying suicidal intent, complicating risk assessment and exposing clinicians to liability.
Key takeaways from the article include:
- Distinct subtypes of LSD include devastating communication, impulsive actions, intoxication, psychosis, and agitated depression, each with unique underlying mechanisms.
- Recognizing LSD has clinical and forensic implications, urging a shift in risk assessment towards dynamic evaluation and targeted interventions.
- The formal categorization of LSD provides a framework for research, aiming to improve understanding and prevention of this complex phenomenon.
The authors state “Acknowledging the existence of LSD is not an admission of defeat; it is a call for greater sophistication in our clinical and systemic approach. It pushes us to understand and account for the powerful role of impulsivity, acute psychosocial stressors, and rapidly changing mental states in the final pathway to suicide. For the clinician on the front lines, it can provide a rationale for taking further action—such as increasing the level of observation, or engaging family—based on a holistic assessment of dynamic risk factors, rather than being solely tethered to a patient’s denial. Alternatively, understanding of LSD may better explain that appropriate risk assessment may still be followed by a fatal event.”
The article is available on the Psychiatric Times website.
